Mini heart pump for children awaiting transplant
Part of Heart & circulation clinical trials.
This trial tests a small heart pump (the Jarvik 2015) designed to support children with severe heart failure who are waiting for a heart transplant. The pump helps the heart pump blood, which may improve strength and organ function while they wait.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must weigh between about 18 and 66 pounds (8 to 30 kg).
- Your child must have a heart condition where both lower chambers (ventricles) are present, such as cardiomyopathy or certain repaired heart defects.
- Your child's heart failure must be very severe — they are in the highest urgency categories (INTERMACS 1 or 2), meaning they need intensive support like a breathing machine or IV medications to maintain blood flow.
- Your child must already be listed for a heart transplant or be eligible to be listed.
- The implant must happen at a participating hospital in the US or Europe.
- Parents or legal guardians must give written permission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study tests whether using a temporary heart pump called Impella 5.5 can help strengthen a very weak and enlarged heart (dilated cardiomyopathy) in people who are waiting for a heart transplant. If you qualify, the pump is placed to support your heart temporarily, and the research team will check how your heart responds.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.